(Q38917815)
Statements
Trabectedin efficacy in Ewing sarcoma is greatly increased by combination with anti-IGF signaling agents (English)
Maria Cristina Manara
Ana Teresa Amaral
Silvana Di Giandomenico
Jose Luis Ordóñez
Victoria Sevillano
Roberta Malaguarnera
21 January 2015